Afobazole Nanoparticles Formulation for Enhanced Therapeutics

A novel nanoparticle drug composition and method of use thereof is presented herein. The nanoparticle drug composition is comprised of at least one nanoparticle carrier, formed from the conjugation of PLGA and PEG, which encapsulates a drug such as afobazole and its derivatives, in a pharmaceutically acceptable carrier. The nanoparticle drug composition may be used to treat various diseases of the central nervous system involving excessive neuronal activity and inflammation such as stroke, Alzheimer's disease and anxiety.

Patents:
US 10,172,867 issued 2019-01-08   [MORE INFO]

Type of Offer: Licensing



« More Science Patents
« More Neurology Patents

---